BioAtla (BCAB) Accumulated Depreciation (2020 - 2026)

BioAtla's Accumulated Depreciation history runs 7 years deep, the most recent figure standing at $5.4 million for Q1 2026.

• On a quarterly basis, Accumulated Depreciation fell 24.46% year-over-year to $5.4 million in Q1 2026; TTM through Mar 2026 was $5.4 million, a 24.46% decrease from a year earlier, with the FY2025 full-year figure at $5.3 million, down 24.2% from the prior year.
• Accumulated Depreciation rose to $5.4 million in Q1 2026 per BCAB's latest filing, from $5.3 million in the prior quarter.
• Across five years, Accumulated Depreciation topped out at $7.4 million in Q3 2025 and bottomed at $4.6 million in Q1 2022.
• The 5-year median for Accumulated Depreciation is $6.1 million (2023), against an average of $6.1 million.
• Across the five-year window, Accumulated Depreciation soared 34.98% in 2022 and declined 24.46% in 2026, its largest moves.
• Year by year, Accumulated Depreciation stood at $5.4 million in 2022, then grew by 13.31% to $6.1 million in 2023, then gained by 15.22% to $7.0 million in 2024, then retreated by 24.2% to $5.3 million in 2025, then increased by 2.26% to $5.4 million in 2026.
• Per Business Quant, the three latest BCAB Accumulated Depreciation figures stand at $5.4 million (Q1 2026), $5.3 million (Q4 2025), and $7.4 million (Q3 2025).